135 related articles for article (PubMed ID: 17180732)
1. Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells.
Kurer MA
Mol Biol Rep; 2007 Dec; 34(4):221-4. PubMed ID: 17180732
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
[TBL] [Abstract][Full Text] [Related]
3. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
4. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL.
Petit L; Lesnik P; Dachet C; Moreau M; Chapman MJ
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):309-15. PubMed ID: 9974412
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Kisiel W
Thromb Haemost; 2010 Jan; 103(1):198-204. PubMed ID: 20062932
[TBL] [Abstract][Full Text] [Related]
7. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells.
Stavik B; Skretting G; Sletten M; Sandset PM; Iversen N
Mol Carcinog; 2010 Nov; 49(11):951-63. PubMed ID: 20886581
[TBL] [Abstract][Full Text] [Related]
9. Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver.
Kataoka H; Uchino H; Asada Y; Hatakeyama K; Nabeshima K; Sumiyoshi A; Koono M
Int J Cancer; 1997 Sep; 72(5):878-84. PubMed ID: 9311608
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture.
Sugawara T; Yamabe H; Osawa H; Kaizuka M; Shirato K; Nakamura M; Tamura M; Okumura K
Thromb Res; 2003 May; 110(2-3):141-7. PubMed ID: 12893029
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
Bajaj MS; Ghosh M; Bajaj SP
J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues.
Bajaj MS; Kuppuswamy MN; Manepalli AN; Bajaj SP
Thromb Haemost; 1999 Sep; 82(3):1047-52. PubMed ID: 10494762
[TBL] [Abstract][Full Text] [Related]
14. The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IκB-α stimulated by tumour necrosis factor-α in cultured vascular smooth muscle cells.
Zhao Y; Fu Y; Hu J; Liu Y; Yin X
Arch Cardiovasc Dis; 2013 Jan; 106(1):4-11. PubMed ID: 23374966
[TBL] [Abstract][Full Text] [Related]
15. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
16. Expression of tissue factor and tissue factor pathway inhibitor in microparticles and subcellular fractions of normal and malignant prostate cell lines.
Lwaleed BA; Lam L; Lasebai M; Cooper AJ
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):339-43. PubMed ID: 23524311
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
18. TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells.
Stavik B; Skretting G; Olstad OK; Sletten M; Dehli Vigeland M; Sandset PM; Iversen N
PLoS One; 2012; 7(10):e47184. PubMed ID: 23071754
[TBL] [Abstract][Full Text] [Related]
19. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
20. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
